알레르기, 천식, 약물 알레르기, 임상면역학에 대한 근거 기반 지식 블로그 — Allergy, Asthma & Clinical Immunology.https://allergy-desk.pages.dev/https://allergy-desk.pages.dev/posts/anaphylaxis-basics/https://allergy-desk.pages.dev/posts/anaphylaxis-basics/아나필락시스의 정의와 진단 기준, 그리고 일차 치료인 에피네프린 근육주사를 중심으로 정리합니다.Tue, 29 Sep 2026 00:00:00 GMTAnaphylaxis아나필락시스에피네프린응급처치https://allergy-desk.pages.dev/posts/nsaid-hypersensitivity/https://allergy-desk.pages.dev/posts/nsaid-hypersensitivity/NSAID 과민반응의 표현형별 분류와, 그에 따른 교차반응 위험 및 COX-2 선택적 억제제의 역할을 정리합니다.Fri, 25 Sep 2026 00:00:00 GMTDrug AllergyNSAIDs교차반응COX-2NERDhttps://allergy-desk.pages.dev/posts/beta-lactam-cross-reactivity/https://allergy-desk.pages.dev/posts/beta-lactam-cross-reactivity/페니실린-세팔로스포린 교차반응 위험이 과대평가되어 왔으며, 곁사슬(side chain) 공유가 핵심이라는 최신 관점을 정리합니다.Sun, 20 Sep 2026 00:00:00 GMTDrug Allergy베타락탐페니실린세팔로스포린교차반응https://allergy-desk.pages.dev/posts/asthma-biologics/https://allergy-desk.pages.dev/posts/asthma-biologics/An overview of the biologic therapies targeting type 2 inflammation in severe asthma, and how phenotype guides choice.Tue, 15 Sep 2026 00:00:00 GMTAsthmabiologicssevere asthmatype 2 inflammation